LSD

LSD is a semi-synthetic ergot alkaloid derivative that produces profound alterations in perception, cognition, and mood. It is one of the most potent psychoactive substances known, with typical doses in the microgram range. LSD is non-toxic at recreational doses but produces intense psychological effects that require careful preparation and set/setting management.

How It Works

Primarily agonizes 5-HT2A serotonin receptors in the prefrontal cortex and anterior cingulate cortex, leading to increased thalamic filtering dysfunction and altered sensory gating. Also acts on multiple serotonin receptor subtypes (5-HT1A, 5-HT1D, 5-HT2C, 5-HT7) as well as dopamine D1/D2 receptors, contributing to its complex neuropsychological effects. Does not significantly affect monoamine release or reuptake.

Legal Status

Schedule I controlled substance in most countries including the United States, United Kingdom, and Australia. Possession, distribution, and manufacture are felonies. Some jurisdictions have decriminalized small quantities for personal use. Currently undergoing clinical research trials for therapeutic applications in PTSD and end-of-life anxiety.

Dosage Guide (Sublingual/Oral)

Note: Street tabs vary widely (25-150μg per tab). Use reagent testing (Ehrlich) to confirm LSD presence. Duration is very long (8-14 hours) — do not redose within 12 hours thinking it isn't working. The come-up takes 45-90 minutes; effects plateau around 2-4 hours. First-time users should start at 50-100μg in a safe setting.

Organ System Impacts

cardiovascular — Low

LSD causes modest sympathomimetic effects: mild increase in heart rate (5-20 bpm), slight elevation in blood pressure (5-15 mmHg systolic), and peripheral vasoconstriction (fingers may feel numb or cold). These changes are transient and resolve with the drug's clearance. No direct cardiotoxicity at recreational doses. Individuals with underlying cardiovascular disease should exercise caution.

neurological — Moderate

Primary site of action. LSD alters perception, mood, cognition, and consciousness. Risk of anxiety, panic, paranoia, depersonalization/derealization, and (rarely) acute psychotic episodes—especially in individuals with genetic predisposition to psychosis or unmanaged psychiatric conditions. No neurotoxicity or neurodegeneration at any dose. Long-term cognitive impairment is not established.

ocular — Low

Pupil dilation (mydriasis) is nearly universal and persists throughout the experience. This is a sympathomimetic effect, not retinal damage. Increased sensitivity to light is common. Blurred accommodation and visual disturbances can occur. No permanent ophthalmological damage or retinal toxicity is documented.

dermatological — Low

LSD does not damage skin or cause dermatitis. Blotter paper contamination or individual allergies can cause localized reactions. Some users report flushing or sweating, which is part of the sympathomimetic response. No direct dermatotoxicity.

respiratory — Low

LSD does not suppress respiration or cause direct respiratory toxicity. Anxiety-related hyperventilation is possible in some users, leading to lightheadedness or paresthesias (tingling). Respiratory rate may increase mildly due to sympathomimetic effects. No risk of respiratory depression or apnea.

hepatic — Low

Liver metabolism of LSD is not significant; LSD is metabolized to inactive metabolites (primarily 2-oxo-LSD and N-demethyl-LSD) via minimal hepatic involvement. No hepatotoxicity, cirrhosis risk, or liver enzyme induction is documented. Safe in individuals with pre-existing liver disease.

hematological — Low

No direct effects on blood composition, coagulation, or red blood cell formation. LSD does not cause anemia, thrombosis, or bleeding disorders. No hematological toxicity at any dose. Safe in individuals with coagulation disorders.

renal — Low

LSD is not nephrotoxic and does not accumulate in the kidneys. Minimal renal metabolism or clearance. No risk of acute kidney injury, chronic kidney disease, or electrolyte imbalances. Safe in individuals with renal impairment (no dose adjustment needed).

gastrointestinal — Low

Nausea occurs less frequently with LSD than with psilocybin but can happen, especially on an empty stomach or with anxiety. Mild appetite suppression is common. Stomach acid degrades some LSD, slightly reducing bioavailability if swallowed (sublingual absorption is more efficient). No ulceration, bleeding, or GI toxicity.

musculoskeletal — Low

LSD may cause mild muscle tension, jaw clenching (bruxism), or tremors, particularly at higher doses. These are sympathomimetic and dissipate post-experience. No risk of muscle breakdown (rhabdomyolysis), permanent weakness, or musculoskeletal degeneration. Physical activity during use is safe but not recommended due to impaired coordination.

Effects

Desired Effects

• Visual enhancements and geometric patterns
• Color intensification and visual field expansion
• Sense of awe, wonder, or spiritual connection
• Increased emotional insight and introspection
• Mild euphoria and mood elevation
• Enhanced sensory appreciation (music, art, nature)
• Feelings of unity or connectedness with surroundings
• Cognitive flexibility and novel perspective shifts
• Enhanced creativity and lateral thinking
• Improved empathy and emotional processing

Negative Effects

• Anxiety and panic (dose and set dependent)
• Paranoia or fear
• Disturbing or frightening visuals
• Emotional overwhelm
• Difficulty concentrating or racing thoughts
• Sense of losing control or detachment from reality (depersonalization/derealization)
• Jaw clenching or teeth grinding
• Vasoconstriction-related discomfort (chest tightness, finger numbness)
• Nausea (though less common than with psilocybin)
• Headache or pressure sensation

Rare but Serious

• Acute psychotic episodes (more likely in individuals with schizotypy or family history of psychosis)
• Severe panic attacks or extreme anxiety requiring emergency intervention
• Serotonin syndrome (if combined with other serotonergic drugs)
• Hypertensive crisis (rare; more likely with MAOI combination)
• Seizures (extremely rare; reported only in literature case reports with very high doses or underlying seizure disorders)
• Persistent perceptual changes (Hallucinogen Persisting Perception Disorder — HPPD)
• Exacerbation of underlying mood or psychotic disorders

Drug Interactions

Detection Times

LSD is active in microgram doses, making detection very difficult. Not on standard panels.

Urine

Requires specialized immunoassay or LC-MS/MS. Very short window. Detection window: up to 3 days.

Blood

Extremely short blood detection window due to tiny doses. Detection window: up to 1 days.

Hair

Hair testing for LSD is possible but rarely performed. Detection window: up to 90 days.

Harm Reduction Tips

• Have benzos available: If severe anxiety or panic develops, a benzodiazepine (e.g., 1-2mg lorazepam or 5-10mg diazepam) can reduce anxiety and serve as a 'trip-killer,' allowing you to sleep through the remaining duration. Discuss with a doctor in advance if possible; a prescription enables emergency access.

• Test your LSD with Ehrlich reagent (indole test): authentic LSD turns purple-violet within 2-3 minutes. Use a reagent test kit from a reliable vendor (DrugsData, EnergyControl, etc.) to confirm substance identity and rule out NBOMe compounds or other impersonators.

• Start with a low dose: First-time users should use 50-100μg in a safe setting. Street tabs vary widely in strength (25-150μg); verify potency via reagent testing. Many bad experiences stem from unexpected high doses.

• Manage physical symptoms: Pupil dilation, slight tremor, mild nausea, and jaw clenching are normal. Drink water, eat light snacks (if tolerated), move to cooler environments if overheating, and use gum or ice chips for jaw clenching. These effects are temporary and resolve with the drug's clearance (usually 12-14 hours after ingestion).

• Ensure a safe, comfortable space: Lock doors, silence phones (or use 'do not disturb' mode), dim lights if sensitive to stimulation, have water and snacks available, and ensure bathroom access. Avoid crowds, loud noise, or challenging social situations.

• Practice set and setting: Mental set (mindset, expectations, mental health status) and physical setting (safe, comfortable environment with trusted people) are crucial. Avoid use if experiencing depression, anxiety, psychosis, or other mental health crises. Choose a calm, familiar environment with low stimulation.

• Avoid redosing: Do not take additional LSD within 12 hours of the initial dose thinking it 'isn't working.' LSD has a slow come-up (45-90 minutes) and long duration (8-14 hours). Effects plateau at 2-4 hours post-ingestion. Tolerance develops rapidly; redosing will not intensify effects and only extends duration.

• Arrange a trip sitter: Have a sober, experienced, trusted person present who will remain sober throughout. The sitter should not use substances, know your dose, understand harm reduction, and be prepared to assist with basic needs or provide grounding if anxiety arises.

• Avoid driving or operating machinery: LSD impairs coordination, judgment, and perception for the entire duration (8-14 hours). Do not drive, use power tools, or perform safety-sensitive tasks. Plan a day off from responsibilities.

• Integrate and reflect afterward: Journaling, talking with your trip sitter, or discussing the experience in writing helps process insights and reduce potential negative psychological effects. Avoid immediately resuming normal responsibilities; allow time for integration.

• Respect the psychological intensity: LSD can temporarily distort your sense of self, reality, and time. These effects are normal and temporary but can be frightening. Remind yourself during anxiety that the experience will end and that you are safe. Grounding techniques (5 senses awareness: name 5 things you see, 4 you hear, 3 you feel, 2 you smell, 1 you taste) can help.

• Avoid use if pregnant or breastfeeding: No studies confirm safety. LSD use during pregnancy is not recommended; defer until after pregnancy and breastfeeding.

Withdrawal Symptoms

Severity: Low

Not applicable — LSD does not cause dependence.

Psychological

• No withdrawal syndrome

Emergency Information

Call 911 If:

• Signs of serotonin syndrome (muscle rigidity, hyperthermia, altered mental status, autonomic instability) are present.
• Chest pain, severe difficulty breathing, or signs of cardiac arrhythmia occur.
• Seizure activity or loss of consciousness occurs.
• Severely elevated body temperature (>40°C/104°F) that does not respond to cooling measures.
• Uncontrollable violent behavior or acute risk of self-harm or harm to others.
• Severe vomiting or inability to maintain hydration.
• Any signs of life-threatening medical emergency (stroke, myocardial infarction, etc.).
• The person has ingested an unknown quantity or unknown substance (concern for NBOMe or other dangerous impersonator).
• Severe psychological distress persists beyond 12-16 hours post-ingestion (unusual; may indicate underlying psychiatric emergency).

Warning Signs

• Severe panic or uncontrollable anxiety
• Paranoia or belief that harm is imminent
• Loss of contact with reality (inability to recognize that you are on a drug and that effects will pass)
• Visual hallucinations that are distressing or uncontrollable
• Severe vasoconstriction (chest pain, difficulty breathing, extreme finger/toe numbness or color change)
• Rapid or severely irregular heartbeat
• Extremely high body temperature (hyperthermia)
• Severe muscle rigidity or tremors
• Seizure activity
• Violent or self-injurious behavior
• Signs of serotonin syndrome (agitation, confusion, muscle rigidity, rapid heart rate, elevated blood pressure, hyperthermia)

What To Do

1. Remain calm and remind yourself or the affected person that the effects are temporary and will pass (usually 8-14 hours).
2. Move to a calm, quiet, dimly lit environment if possible.
3. If a benzodiazepine is available and the person is willing, administer (e.g., 1-2mg lorazepam or 5-10mg diazepam). This is the most effective emergency intervention.
4. Use grounding techniques: ask the person to name 5 things they see, 4 they hear, 3 they feel, 2 they smell, 1 they taste. Encourage slow, deep breathing.
5. Provide reassurance: remind the person they took a drug, that the experience will end, and that they are safe.
6. Ensure hydration (water only) and cool temperature to prevent overheating.
7. Do NOT restrain the person unless they pose an immediate danger to themselves or others; restraint can increase panic.
8. Do NOT argue about whether the experience is 'real' or minimize their distress; validate their feelings while reorienting to reality.